Erster O, Thomas JM, Hamzah J, Jabaiah AM, Getz JA, Schoep TD, Hall SS, Ruoslahti E, Daugherty PS.  2012.  Site-specific targeting of antibody activity< i> in vivo mediated by disease-associated proteases. Journal of Controlled Release. 161:804–812.

Brunquell C, Biliran H, Jennings S, Ireland SKale, Chen R, Ruoslahti E.  2012.  TLE1 Is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. Molecular Cancer Research. 10:1482–1495.

Chen R, Braun GB, Luo X, Sugahara KN, Teesalu T, Ruoslahti E.  2013.  Application of a proapoptotic peptide to intratumorally spreading cancer therapy. Cancer research. 73:1352–1361.

Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi G-P, Ruoslahti E.  2013.  De novo design of a tumor-penetrating peptide. Cancer research. 73:804–812.

Agemy L, Kotamraju VR, Friedmann-Morvinski D, Sharma S, Sugahara KN, Ruoslahti E.  2013.  Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. Molecular Therapy. 21:2195–2204.

Kolhar P, Anselmo AC, Gupta V, Pant K, Prabhakarpandian B, Ruoslahti E, Mitragotri S.  2013.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proceedings of the National Academy of Sciences. 110:10753–10758.

Pang H-B, Braun GB, Friman T, Aza-Blanc P, Ruidiaz ME, Sugahara KN, Teesalu T, Ruoslahti E.  2014.  An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability. Nature communications. 5

Braun GB, Friman T, Pang H-B, Pallaoro A, de Mendoza THurtado, Willmore A-MA, Kotamraju VRamana, Mann AP, She Z-G, Sugahara KN et al..  2014.  Etchable plasmonic nanoparticle probes to image and quantify cellular internalization. Nature materials.

Hu Q, Chen R, Teesalu T, Ruoslahti E, Clegg DO.  2014.  Reprogramming Human Retinal Pigmented Epithelial Cells to Neurons Using Recombinant Proteins. Stem cells translational medicine. 3:1526–1534.